Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D015248:Gemfibrozil; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009203:Myocardial Infarction / Q000517:prevention & control; D010421:Pentanoic Acids / Q000627:therapeutic use*; D014631:Valerates / Q000627:therapeutic use*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010421:Pentanoic Acids; D014631:Valerates; D002784:Cholesterol; D015248:Gemfibrozil